Oncofocus
  • Services
    • Primary Market Research
    • Competitive Intelligence
  • About
  • Blog
  • Reports
  • Careers
  • Contact
CAR-T Agents
​​
ASCO 2018 Post-conference Report 
​oncofocus
ASCO 2018 annual meeting is over and, like last year's conference, several key findings were presented. We have been actively tracking developments in the CAR-T space and had published a pipeline landscape report before the conference. If you have not already read it, you can do so by downloading it HERE.

We are now completing the series – CAR-Ts in ASCO – with a report summarizing key updates concerning clinical stage CAR-Ts at ASCO 2018. 

The data presented covered major aspects of the CAR-Ts’ use case in the Oncology treatment landscape, for example –
  • Positive efficacy and safety data bringing two more CAR-Ts closer to filing/approval by 2019
  • Potential prognostic factors to distinguish patients who can attain long-termclinical benefits
  • Genetic biomarkers that could be helpful in identifying patients prone to neurotoxicity​​
  • Optimal sequenceof the CAR-Ts in the present treatment regimen

​You can download our Post-conference report by fillling the form. Please do let us know your thoughts/suggestions on our work. We would be happy to receive your feedback.

Happy Reading!
Bangalore Office
Oncofocus Solutions Pvt Ltd, 

#4, II Floor, 5th Main, 9th Cross, Jaya Mahal Ext,
Bengaluru
, India 56 00 46

Tel. +91 89044 00482

E-mail: support@oncofocus.com
RFQ: rfq@oncofocus.com
​

Singapore Office (Sales)
Oncofocus Solutions Pte Ltd, 

51 Goldhill Plaza, 
#07-10/11
​Singapore 30 89 00
​



E-mail: support@oncofocus.com.sg
​RFQ: rfq@oncofocus.com
​

    Subscribe to our Newsletter

Subscribe to Newsletter
Tweets by oncofocus
Photo used under Creative Commons from NIAID
  • Services
    • Primary Market Research
    • Competitive Intelligence
  • About
  • Blog
  • Reports
  • Careers
  • Contact